AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Guardant Health Director Sells 100 Shares at $65.84 on 2025-09-02
ByAinvest
Wednesday, Sep 3, 2025 6:56 pm ET1min read
Guardant Health, Inc. (GH) announced that Director Joyce Meghan V. has recently sold 100 shares at a price of $65.84 per share on September 2, 2025.
Title: Guardant Health, Inc. Director Joyce Meghan V. Sells 100 Shares on September 2, 2025Guardant Health, Inc. (GH) has announced that Director Joyce Meghan V. sold 100 shares of the company's common stock on September 2, 2025. The shares were sold at a price of $65.84 per share, resulting in an aggregate market value of $6,584.
The transaction was executed through Charles Schwab & Co., Inc. and is part of the company's equity compensation program. The shares were acquired by Director Joyce Meghan V. through restricted stock lapses: 34 shares on June 12, 2025, and 66 shares on July 4, 2025. These shares were listed as part of the company's compensation package [1].
This sale is part of a series of recent insider transactions. In June 2025, Director Joyce Meghan V. sold 100 shares for $4,166 on June 2, 2025, and 3,337 shares for $157,573 on June 13, 2025. The filings disclose these transactions, providing transparency to investors and regulatory bodies [1].
The recent positive performance of Guardant Health's stock, which has seen a 4.82% increase amid promising new growth plans and strategic partnerships, may have influenced the sale. The company has recently formed a partnership with the American Cancer Society to enhance cancer screenings and promote health equity [2]. Additionally, analysts have revised their price targets upward, reflecting the company's robust financial guidance and promising future outlook [2].
Despite the recent insider sales, the overall market sentiment for Guardant Health remains positive. The company's strategic partnerships and financial performance are seen as strong drivers of future growth.
References:
[1] https://www.stocktitan.net/sec-filings/GH/144-guardant-health-inc-sec-filing-c59cd2c49d75.html
[2] https://stockstotrade.com/news/guardanthealthinc-gh-news-2025_08_30/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet